Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 2OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 70Leukemia 35Burkitt Lymphoma 10Lymphoma 8Neoplasm, Residual 6Leukemia, Myeloid, Acute 4Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Leukemia, T-Cell 3Leukemia, Promyelocytic, Acute 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm Metastasis 2Psoriasis 1Philadelphia Chromosome 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Mucositis 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Erythroblastic, Acute 1Leukemia, B-Cell 1Inflammatory Bowel Diseases 1Glioblastoma 1Drug-Related Side Effects and Adverse Reactions 1Down Syndrome 1Breast Neoplasms 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1Blast Crisis 1

Interventions

Daunorubicin 2Cytarabine 2prednylidene 1Vincristine 1Prednisolone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Hydrocortisone 1Etoposide 1Epirubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Down Syndrome × Mercaptopurine × Clear all
NCT03286634 2026-05-11

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

National Hospital Organization Nagoya Medical Center

Phase 2 Active not recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡